A citation-based method for searching scientific literature

F Lécuru, M A Le Frère Belda, A S Bats, L Tulpin, U Metzger, S Olschwang, P Laurent-Puig. Int J Gynecol Cancer 2008
Times Cited: 31







List of co-cited articles
315 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.
Laura Renkonen-Sinisalo, Ralf Bützow, Arto Leminen, Pentti Lehtovirta, Jukka-Pekka Mecklin, Heikki J Järvinen. Int J Cancer 2007
133
74

Gynecologic screening in hereditary nonpolyposis colorectal cancer.
Fleur E M Rijcken, Marian J E Mourits, Jan H Kleibeuker, Harry Hollema, Ate G J van der Zee. Gynecol Oncol 2003
114
70

The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.
Isis Dove-Edwin, Dominique Boks, Sheila Goff, Gemma G Kenter, Robert Carpenter, Hans F A Vasen, Huw J W Thomas. Cancer 2002
145
67

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.
Lotte H M Gerritzen, Nicoline Hoogerbrugge, Angèle L M Oei, Fokko M Nagengast, Maaike A P C van Ham, Leon F A G Massuger, Joanne A de Hullu. Fam Cancer 2009
46
58

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
482
54

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
Noralane M Lindor, Gloria M Petersen, Donald W Hadley, Anita Y Kinney, Susan Miesfeldt, Karen H Lu, Patrick Lynch, Wylie Burke, Nancy Press. JAMA 2006
426
45

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
626
45

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
Janice S Kwon, Charlotte C Sun, Susan K Peterson, Kristin G White, Molly S Daniels, Stephanie G Boyd-Rogers, Karen H Lu. Cancer 2008
65
41


Cancer risk in mutation carriers of DNA-mismatch-repair genes.
M Aarnio, R Sankila, E Pukkala, R Salovaara, L A Aaltonen, A de la Chapelle, P Peltomäki, J P Mecklin, H J Järvinen. Int J Cancer 1999
815
41


Cancer risk associated with germline DNA mismatch repair gene mutations.
M G Dunlop, S M Farrington, A D Carothers, A H Wyllie, L Sharp, J Burn, B Liu, K W Kinzler, B Vogelstein. Hum Mol Genet 1997
495
38

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, D G Evans. Clin Genet 2009
198
35


Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.
Yvonne M C Hendriks, Anja Wagner, Hans Morreau, Fred Menko, Astrid Stormorken, Franz Quehenberger, Lodewijk Sandkuijl, Pal Møller, Maurizio Genuardi, Hans Van Houwelingen,[...]. Gastroenterology 2004
282
32

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
938
32

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
Patrice Watson, Hans F A Vasen, Jukka-Pekka Mecklin, Inge Bernstein, Markku Aarnio, Heikki J Järvinen, Torben Myrhøj, Lone Sunde, Juul T Wijnen, Henry T Lynch. Int J Cancer 2008
376
32

Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, Päivi Peltomäki, Lauri A Aaltonen, Jukka-Pekka Mecklin. J Clin Oncol 2009
185
32

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Heather Hampel, Julie A Stephens, Eero Pukkala, Risto Sankila, Lauri A Aaltonen, Jukka-Pekka Mecklin, Albert de la Chapelle. Gastroenterology 2005
281
32

Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
S Stuckless, J Green, L Dawson, B Barrett, M O Woods, E Dicks, P S Parfrey. Clin Genet 2013
26
38

Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.
Mark A Jenkins, Laura Baglietto, James G Dowty, Christine M Van Vliet, Letitia Smith, Leeanne J Mead, Finlay A Macrae, D James B St John, Jeremy R Jass, Graham G Giles,[...]. Clin Gastroenterol Hepatol 2006
122
29

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
H F Vasen, A Stormorken, F H Menko, F M Nagengast, J H Kleibeuker, G Griffioen, B G Taal, P Moller, J T Wijnen. J Clin Oncol 2001
270
29

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
949
29

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
29

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Elena Stoffel, Bhramar Mukherjee, Victoria M Raymond, Nabihah Tayob, Fay Kastrinos, Jennifer Sparr, Fei Wang, Prathap Bandipalliam, Sapna Syngal, Stephen B Gruber. Gastroenterology 2009
242
29

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
R Fishel, M K Lescoe, M R Rao, N G Copeland, N A Jenkins, J Garber, M Kane, R Kolodner. Cell 1993
29


Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.
N C Nicolaides, N Papadopoulos, B Liu, Y F Wei, K C Carter, S M Ruben, C A Rosen, W A Haseltine, R D Fleischmann, C M Fraser. Nature 1994
29

Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Laura Baglietto, Noralane M Lindor, James G Dowty, Darren M White, Anja Wagner, Encarna B Gomez Garcia, Annette H J T Vriends, Nicola R Cartwright, Rebecca A Barnetson, Susan M Farrington,[...]. J Natl Cancer Inst 2010
245
29

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013
448
29

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
Rebecca A Barnetson, Albert Tenesa, Susan M Farrington, Iain D Nicholl, Roseanne Cetnarskyj, Mary E Porteous, Harry Campbell, Malcolm G Dunlop. N Engl J Med 2006
317
25

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).
H F A Vasen, G Möslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, G Capella, C Engel, I Frayling,[...]. J Med Genet 2007
364
25

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.
C E Bronner, S M Baker, P T Morrison, G Warren, L G Smith, M K Lescoe, M Kane, C Earabino, J Lipford, A Lindblom. Nature 1994
25

Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.
Y Akiyama, H Sato, T Yamada, H Nagasaki, A Tsuchiya, R Abe, Y Yuasa. Cancer Res 1997
366
25

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
John Burn, Anne-Marie Gerdes, Finlay Macrae, Jukka-Pekka Mecklin, Gabriela Moeslein, Sylviane Olschwang, Diane Eccles, D Gareth Evans, Eamonn R Maher, Lucio Bertario,[...]. Lancet 2011
607
25

Estimating cancer risk in HNPCC by the GRL method.
Flora Alarcon, Christine Lasset, Jérôme Carayol, Valérie Bonadona, Hervé Perdry, Françoise Desseigne, Qing Wang, Catherine Bonaïti-Pellié. Eur J Hum Genet 2007
40
25

Mutation of a mutL homolog in hereditary colon cancer.
N Papadopoulos, N C Nicolaides, Y F Wei, S M Ruben, K C Carter, C A Rosen, W A Haseltine, R D Fleischmann, C M Fraser, M D Adams. Science 1994
25

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D Potter, Annika Lindblom, Kristina Lagerstedt, Stephen N Thibodeau, Noralane M Lindor,[...]. Gastroenterology 2008
355
25

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
F S Leach, N C Nicolaides, N Papadopoulos, B Liu, J Jen, R Parsons, P Peltomäki, P Sistonen, L A Aaltonen, M Nyström-Lahti. Cell 1993
25

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
Noralane M Lindor, Kari Rabe, Gloria M Petersen, Robert Haile, Graham Casey, John Baron, Steve Gallinger, Bharati Bapat, Melyssa Aronson, John Hopper,[...]. JAMA 2005
391
22

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991
22

Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
Fay Kastrinos, Elena M Stoffel, Judith Balmaña, Ewout W Steyerberg, Rowena Mercado, Sapna Syngal. Cancer Epidemiol Biomarkers Prev 2008
51
22

Risks of less common cancers in proven mutation carriers with lynch syndrome.
Christoph Engel, Markus Loeffler, Verena Steinke, Nils Rahner, Elke Holinski-Feder, Wolfgang Dietmaier, Hans K Schackert, Heike Goergens, Magnus von Knebel Doeberitz, Timm O Goecke,[...]. J Clin Oncol 2012
182
22

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
Marlies J E Kempers, Roland P Kuiper, Charlotte W Ockeloen, Pierre O Chappuis, Pierre Hutter, Nils Rahner, Hans K Schackert, Verena Steinke, Elke Holinski-Feder, Monika Morak,[...]. Lancet Oncol 2011
177
22

Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
Christoph Engel, Nils Rahner, Karsten Schulmann, Elke Holinski-Feder, Timm O Goecke, Hans K Schackert, Matthias Kloor, Verena Steinke, Holger Vogelsang, Gabriela Möslein,[...]. Clin Gastroenterol Hepatol 2010
105
22

Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome.
M Aarnio, R Salovaara, L A Aaltonen, J P Mecklin, H J Järvinen. Int J Cancer 1997
107
22

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Hans F A Vasen, Mohamed Abdirahman, Richard Brohet, Alexandra M J Langers, Jan H Kleibeuker, Mariette van Kouwen, Jan Jacob Koornstra, Henk Boot, Annemieke Cats, Evelien Dekker,[...]. Gastroenterology 2010
164
22

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
568
22

No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer.
L Renkonen-Sinisalo, P Sipponen, M Aarnio, R Julkunen, L A Aaltonen, S Sarna, H J Järvinen, J P Mecklin. Scand J Gastroenterol 2002
56
22



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.